Home SomaServe

SomaServe

In operation
Series A
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

SomaServe, originating from a laboratory in Cambridge, UK, is pioneering new drugs that can cross the blood-brain barrier (BBB) and other biological barriers. Through collaboration with partners, SomaServe is developing proprietary technology called PolyNaut, a versatile nano-engineered polymer technology for intracellular delivery. SomaServe works with pharmaceutical and biotechnology partners to innovate and solve problems in the fields of neurology, oncology, and immune diseases.
SomaServe Limited
Cambridge,England,United Kingdom
less than 15 people
October 11, 2018
info@somaserve.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Cell Technology
Concept
Tumor Immune System Diseases # Nervous System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Nanotechnology